Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Sumitomo Seika Chemicals, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 17% Increase, Highest in Two Terms
4008 Sumitomo Seika Chemicals Company,Limited. 【J-GAAP】
Earnings ReportSumitomo Seika Chemicals Company,Limited. <4008> [TSE Prime] announced its financial results in the afternoon session on February 7th (14:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) expanded 9.6 billion yen, an increase 49.2% compared to the same period last year.
In addition, the full-year consolidated ordinary profit has been revised upward 20.0%, from the previous forecast of 10 billion yen to 12 billion yen (compared to 10.2 billion yen in the previous period), reaches new record high for the first time in two terms, turning to a 17.1% increase in the consolidated ordinary profit outlook.
Based on the full-year plan announced by the company after the upward revision, our estimate of the consolidated ordinary profit for the October to March period (2H) is expected to increase 37.9%, from the previous forecast of 5.27 billion yen to 7.27 billion yen (compared to 6.01 billion yen in the same period of the previous year), turning to a 20.9% increase in the consolidated ordinary profit outlook.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit surged 2.2 times that of the same period last year, reaching 4.87 billion yen. The operating profit margin improved from 6.8% in the same period last year to 9.8%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 108,796 | 9,941 | 10,139 | 7,932 | 588.0 | 92.8 | Feb 6, 2023 | J-GAAP |
Apr - Dec, 2023 | 107,243 | 6,328 | 6,435 | 4,025 | 298.8 | 62.8 | Feb 6, 2024 | J-GAAP |
Apr - Dec, 2024 | 112,662 | 8,689 | 9,603 | 6,903 | 520.4 | 80.0 | Feb 7, 2025 | J-GAAP |
YoY | +5.1% | +37.3% | +49.2% | +71.5% | +74.2% |
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2024 Prev | 73,025 | 5,095 | 5,272 | 3,671 | 280.1 | 100 | Nov 11, 2024 | J-GAAP |
Oct - Mar, 2024 New | 75,025 | 6,095 | 7,272 | 5,171 | 394.5 | 100 | Feb 7, 2025 | J-GAAP |
Revision Rate | +2.7% | +19.6% | +37.9% | +40.9% | +40.9% |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2025 Prev | 147,000 | 10,000 | 10,000 | 7,000 | 534.1 | 200 | May 13, 2024 | J-GAAP |
Mar, 2025 New | 149,000 | 11,000 | 12,000 | 8,500 | 648.5 | 200 | Feb 7, 2025 | J-GAAP |
Revision Rate | +1.4% | +10.0% | +20.0% | +21.4% | +21.4% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 73,322 | 5,751 | 6,014 | 3,301 | 245.7 | 100 | May 13, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 75,025 | 6,095 | 7,272 | 5,171 | 394.5 | 100 | Feb 7, 2025 | J-GAAP |
YoY | +2.3% | +6.0% | +20.9% | +56.6% | +60.6% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 143,041 | 10,454 | 10,929 | 8,592 | 636.8 | 200 | May 12, 2023 | J-GAAP |
Mar, 2024 | 142,986 | 9,529 | 10,247 | 6,166 | 459.0 | 200 | May 13, 2024 | J-GAAP |
Mar, 2025 Guidance | 149,000 | 11,000 | 12,000 | 8,500 | 648.5 | 200 | Feb 7, 2025 | J-GAAP |
YoY | +4.2% | +15.4% | +17.1% | +37.9% | +41.3% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 37,579 | 2,550 | 2,202 | 1,160 | 86.1 | 6.8 | Feb 6, 2024 | J-GAAP |
Jan - Mar, 2024 | 35,743 | 3,201 | 3,812 | 2,141 | 159.4 | 9.0 | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 36,896 | 2,911 | 3,553 | 2,521 | 189.6 | 7.9 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 37,079 | 1,994 | 1,175 | 808 | 60.8 | 5.4 | Nov 11, 2024 | J-GAAP |
Oct - Dec, 2024 | 38,687 | 3,784 | 4,875 | 3,574 | 269.4 | 9.8 | Feb 7, 2025 | J-GAAP |
YoY | +2.9% | +48.4% | +121.4% | +208.1% | +212.9% |
Related Articles
Miyakoshi Holdings, Oct-Dec (3Q) Ordinary Profit Increases by 14%
TAKASAGO TEKKO, Oct-Dec (3Q) Ordinary Profit Decreases by 9%
FJ NEXT, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5%, Oct-Dec Ordinary Profit Increases by 2.8 times
Sanyo Trading, Oct-Dec (1Q) Ordinary Profit Increases by 14%
Furukawa Battery, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3.1 times, Oct-Dec Ordinary Profit Increases by 2.2 times
NIHON FALCOM, Oct-Dec (1Q) Ordinary Profit Decreases by 73%, Exceeds First Half Plan
NIPRO, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 30%
TOHO HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 18%, Oct-Dec Ordinary Profit Increases by 31%
Mochida Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 78%
HOKURIKU GAS, Apr-Dec (Cumulative 3Q) Net Income Loss Narrows, Oct-Dec Net Income Loss Narrows